A migraine pill which could change the lives of thousands of people who suffer from the 'incredibly debilitating' condition should be made accessible on the NHS 'swiftly', a charity has said. Atogepant - sold under the brand name Aquipta and made by AbbVie - has been given the green light for NHS use under new final draft guidance from the National Institute for Health and Care Excellence .
Read more on Sky News: Xylazine: Powerful 'zombie drug' known as Tranq has 'penetrated' UK market, experts warnBridget Jones is back: Zellweger will star in fourth film - but a key love interest won't return 'We now need to ensure access is swift, so that migraine patients can benefit from them as quickly as possible.
Source: Healthcare Press (healthcarepress.net)
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
'Very profitable' 170-year-old hotel in Scottish Highlands on saleA 170-YEAR-OLD hotel in the Highlands has been put on the market ...
Source: SunScotNational - 🏆 49. / 63 Read more »
Source: itvnews - 🏆 69. / 61 Read more »
Source: nottslive - 🏆 96. / 52 Read more »
Source: EchoWhatsOn - 🏆 74. / 59 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: DailyMailUK - 🏆 7. / 90 Read more »